Category: Asthma Clinical Trials U.S.
-
World Asthma Day Summary
On the day after World Asthma Day, May 3, 2022, we scanned the globe to find a statement that best sums up the current state of affairs regarding Asthma. Kudos to tbe U.S National Institute of Environmental Health NIH Statement on World Asthma Day 2022: Toward Improved Asthma Care Good enough of summary that we…
-
Interventions To Help Asthma Clinical Adherence
Conditions: Asthma/Drug Therapy; Medication Adherence/Statistics & Numerical Data; Reminder Systems; Humans; Hispanic Americans; Communication Barriers; ChildInterventions: Device: SmartInhaler with reminder function turned on; Device: SmartInhalerSponsors: University of California, San Francisco; Academic Pediatric AssociationNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
Conditions: Asthma; Moderate AsthmaInterventions: Drug: REGN3500; Drug: PlaceboSponsors: Regeneron Pharmaceuticals; SanofiNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty
Conditions: Total Knee Arthroplasty; Pain, Postoperative; Adductor Canal BlockInterventions: Procedure: Multimodal Peripheral Nerve Block Injection; Procedure: Single Shot Adductor Canal BlockSponsor: Wake Forest School of MedicineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
Condition: AsthmaInterventions: Drug: Fluticasone furoate (FF) Dry Powder Inhaler; Drug: Fluticasone propionate (FP) Dry Powder Inhaler; Drug: Budesonide (BUD) Turbuhaler; Drug: Placebo (ELLIPTA or DISKUS)Sponsor: GlaxoSmithKlineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study
Condition: AsthmaIntervention: Device: anharmonic morphological analysis of the respiratory signals (AMARS)Sponsor: University Hospital, BordeauxRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Chronic Widespread Pain and White Blood Cell Activation
Condition: Widespread Chronic PainInterventions: Drug: Ketotifen Fumarate; Drug: Placebo; Other: Standard of CareSponsors: McGill University Health Center; The Louise And Alan Edwards FoundationRecruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Condition: AsthmaInterventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: PlaceboSponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study
Condition: Severe AsthmaIntervention: Sponsors: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA); University Medical Center GroningenRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days